Lenox D. Martin
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Pain Mechanisms and Treatments, Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Mast cells and histamine, Asthma and respiratory diseases
Most-Cited Works
- → Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration(1998)421 cited
- → Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs(2002)90 cited
- → Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation(1999)76 cited
- → Evaluation of Potent and Selective Small-Molecule Antagonists for the CXCR2 Chemokine Receptor(2004)74 cited
- → Selectivity of ZD4522 for inhibition of cholesterol synthesis in hepatic versus non-hepatic cells(2000)57 cited
- → In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non‐peptide NK3 receptor antagonists(1997)35 cited
- → (E)-3-[6-[[(2,6-Dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2- propenoic Acid: A High-Affinity Leukotriene B4 Receptor Antagonist with Oral Antiinflammatory Activity(1996)21 cited
- → (E)-3-[[[[6-(2-Carboxyethenyl)-5-[[8-(4-methoxyphenyl)octyl]oxy]-2-pyridinyl]methyl]thio]methyl]benzoic Acid and Related Compounds: High Affinity Leukotriene B4 Receptor Antagonists(1994)15 cited
- → Analgetic Activity of SK&F 105809, a Dual Inhibitor of Arachidonic Acid Metabolism(1991)14 cited
- → Targeted Disruption of the Endothelin-B-Receptor Gene Attenuates Inflammatory Nociception and Cutaneous Inflammation in Mice(2000)13 cited